Zacks.com on MSN7h
Boston Scientific Stock Set to Gain From Completion of Axonics DealBoston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...
Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...
Delhi: Boston Scientific Corporation, a leading medical device manufacturer, has announced the launch of its ...
Boston Scientific announced the acquisition in January, but the review timeline dragged on after the Federal Trade Commission ...
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...
for stroke risk reduction in patients with non-valvular atrial fibrillation following a cardiac ablation were presented at ...
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Boston Scientific (BSX – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback